Markets › India › NSE › JENBURPH

Jenburkt Pharmaceuticals Ltd

NSE:JENBURPHHealth Technology

₹920.95−0.27%At closeAt close · Mon 19 Oct · ≈ AED 35.53 · Market cap $42.47M

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	40.2%	42.7%	44.7%	46.0%	47.4%	48.3%	+0.9 pts
Operating margin	17.2%	20.5%	20.9%	22.1%	25.4%	25.6%	+0.2 pts
Net margin	15.1%	18.0%	18.0%	18.3%	21.1%	20.6%	−0.5 pts
EBITDA margin	19.0%	22.0%	22.6%	23.7%	27.2%	27.4%	+0.2 pts
Return on equity	16.8%	19.0%	20.1%	17.9%	18.7%	17.6%	−1.0 pts
Return on assets	13.6%	15.6%	17.4%	15.7%	16.3%	15.4%	−1.0 pts
Return on capital employed	18.2%	20.9%	22.7%	21.1%	21.7%	21.3%	−0.4 pts
Debt / equity	0.1×	0.1×	0.0×	0.0×	0.0×	0.0×	−43.9%
Debt / assets	4.2%	4.7%	2.1%	0.0%	2.0%	1.1%	−0.9 pts
Interest coverage	39.6×	58.4×	78.0×	115.8×	85.0×	93.4×	+9.9%
Current ratio	4.4×	3.6×	5.1×	6.7×	3.0×	4.1×	+36.8%
Quick ratio	4.0×	3.1×	4.6×	6.2×	2.5×	3.4×	+37.5%
Cash ratio	0.2×	0.3×	0.3×	0.3×	0.4×	0.3×	−36.8%
Asset turnover	0.9×	0.9×	1.0×	0.9×	0.8×	0.7×	−3.4%
Inventory turnover	8.2×	7.1×	9.0×	8.9×	8.5×	5.7×	−33.2%
Receivables turnover	6.0×	7.2×	6.5×	5.8×	7.0×	5.7×	−18.5%
Dividend payout	0.0%	21.0%	22.4%	24.3%	21.1%	22.9%	+1.7 pts